Aurobindo Pharma Ltd Future - Aug 26

Currency in INR
1,643.70
-17.90(-1.08%)
Closed·

ARBNc1:NS Comments

buy target 795 in sep
Demerger in the company GOLD buy around 945/-
Buy
900 level not break
Advertisement
buy
Auropharma Fut CMP-789.90, Short Sell Below 789 sustain. . T1-786.15. T2-782.20. T3-777.05. T4-766. . R1-790.60. R2-795. R2-798. . Weak SL-796.55. . Conservative SL-798.65. . Strict SL-802.55. . Trend: Bearish. Direction: Down. . Remain Full Dead Below-790.60 . . Free Fall/ Vertical Only below 775.75 crackdown. . Bull Only above 801.65 cross @ Sustain . . Above 795.35 Cross and sustain then bears will get in Trouble / Danger. . First Sign of strength above if continues Sustain 794. . Above 794 minor Positive. . Remain Weak below-789
sell auro fut
what is the status of auro pharma now its goin on buy or sell trend
Advertisement
Buy Aurobindo @ 698 will cross 725 by mid Sept..
Sell auropharma 624.50 for target 613-609 with SL 631.95
All target done total 15 points profit
Qq
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.